CDMRP Gulf War Illness Research Program GWIRP -preapplication due May 29, 2020
https://cdmrp.army.mil/funding/gwirp

• New Investigator Award
• Research Advancement Award
• Idea Award
• Clinical Evaluation Award
• Therapeutic/Biomarker Trial Award
• Patient-Provider and Health Communications Award

GWI is characterized by multiple, diverse symptoms that typically include chronic headache, widespread pain, cognitive difficulties, debilitating fatigue, gastrointestinal problems, respiratory symptoms, sleep problems, and other abnormalities that could not be explained by established medical diagnoses or standard laboratory tests. Studies indicate that approximately 25-32% of Gulf War Veterans continue to experience symptoms associated with their deployment.

The GWIRP focuses on funding innovative, competitively peer-reviewed research to (1) provide a better understanding of the pathobiology underlying GWI, (2) identify objective markers (biomarkers) for improved diagnosis, and (3) to develop treatments for the complex of GWI symptoms and their underlying causes.